A relatively new, family owned pharmaceutical company called Pharmaco International, which is located in Muskegon, Michigan, has come up with a formula it says can be mixed with a propellant and inhaled to prevent inflammation caused by an abnormal response to common allergens and other asthma triggers. The medicine has two functions:
- It blocks the release of inflammatory markers that cause the asthma and allergy response
- It creates a steady release of the hormone cortisol which helps reduce inflammation
Because it comes in inhaler form, it will have to be used prior to exposure to allergens or asthma triggers. So, chances are most asthmatics will have to use the medicine daily, and for many of us more than once per day. This may be burdensom, yet perhaps worthwhile if the medicine works out as expected.
The FDA has not yet been presented with papers for approval Other diseases the medicine is believed to cure are:
- Nasal allergies
- Acute Bronchitis